Kyndryl (US:KD) Prnewswire·2026-02-24 09:00Core Insights - Kyndryl and the University of Liverpool are collaborating to develop next-generation healthcare technologies using AI, specifically through Kyndryl's Agentic AI Framework and the University's research expertise [1] - The initiative aims to enhance patient interaction and healthcare services, particularly for underserved populations, by creating AI-driven solutions such as conversational AI services [1] - The collaboration aligns with the Liverpool City Region's Life Sciences Innovation Zone, positioning the area as a hub for health and life sciences innovation [1] Group 1: Collaboration Details - The partnership will co-develop blueprints for healthcare technologies, focusing on AI projects that improve patient experiences [1] - Phase one of the collaboration will evaluate conceptual AI projects aimed at enhancing patient interaction and healthcare service utilization [1] - The projects will utilize population health datasets and testbed environments to create a library of innovation-ready models [1] Group 2: Impact and Goals - The collaboration seeks to address significant health disparities in the Liverpool area, where life expectancy can differ by up to 15 years between affluent and disadvantaged communities [1] - The initiative aims to provide more preventive and personalized care while effectively targeting resources to assist vulnerable populations [1] - Kyndryl's AI innovation lab, launched in May 2025, will play a crucial role in developing solutions for real-world health challenges [1] Group 3: Institutional Background - Kyndryl is a leading provider of mission-critical enterprise technology services, operating in over 60 countries [1] - The University of Liverpool is a prominent research-intensive institution with an annual turnover of £708.3 million and a research income of £163.1 million [1] - The University is ranked among the top 150 universities globally and is a member of the Russell Group, reflecting its significant academic influence [1]